中芯國際(688981.SH):目前正積極與聯合CEO梁孟鬆核實其真實辭任意願
格隆匯12月16日丨中芯國際(688981.SH)公告稱,公司的董事會注意到,有媒體報道公司執行董事及聯合首席執行官梁孟鬆博士擬辭任公司職務的消息,並且公司已知悉樑博士其有條件辭任的意願。
公司目前正積極與樑博士核實其真實辭任的意願,任何關於上述事宜的進一步公告將根據《香港聯合交易所有限公司證券上市規則》及《上海證券交易所科創板股票上市規則》適時作出。任何公司最高管理層人事變動,以公司發佈公告為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.